Picture EBD Group World of Partnering Opportunities 650x100px

Collaboration › Details

Bruker–William Blair: investor conference, 201806 supply service Bruker presents at William Blair Annual Growth Stock Conference in Chicago

	Period	2018-06-13
	Region	Chicago, IL
	Country	United States (USA)
	Predecessor	Bruker–William Blair: investor conference, 201706 supply service Bruker presents at William Blair Annual Growth Stock Conference in Chicago
	Partner, 1st	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Partner, 2nd	William Blair & Company LLC
	Group	William Blair (Group)
	Product	William Blair & Company Annual Growth Stock Conference 2018 Chicago
	Product 2	analytical instrument
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel)

Bruker Corporation. (6/4/18). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA.

Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences:

Jefferies 2018 Global Healthcare Conference, New York, NY
Thursday, June 7, 2018, at 8:30 a.m. Eastern Time
Frank Laukien, President and Chief Executive Officer
Juergen Srega, President, Bruker CALID Group

William Blair 38th Annual Growth Stock Conference, Chicago, IL
Wednesday, June 13, 2018, at 8:40 a.m. Central Time
Frank Laukien, President and Chief Executive Officer
Gerald Herman, Interim Chief Financial Officer

A live audio webcast of Bruker's Jefferies 2018 Global Healthcare Conference presentation will be available on the Investor Relations section of the Company's Web site at https://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (NASDAQ: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

Contact :

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com